Xilio Therapeutics, Inc. (XLO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 74.9M |
| Enterprise Value | -55.68M |
| P/E Ratio | -34.8 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 1.04 |
| Price/Book Ratio | 2.51 |
| Enterprise/Revenue | -1.07 |
| Enterprise/EBITDA | 5.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.21 |
| Operating Margin | -0.75 |
| Return On Assets | -0.09 |
| Return On Equity | -0.19 |
| Revenue | 43.77M |
| Revenue/Share | 2.79 |
| Gross Profit | 42.23M |
| EBITDA | -33.49M |
| Net Income | -35.04M |
| Diluted EPS | -4.19 |
| Total Cash | 122.18M |
| Total Cash/Share | 6.21 |
| Total Debt | 5.96M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 4.72 |
| Book Value Per Share | 3.47 |
| 52-Week Change | -21.76 |
| 52-Week High | 11.3 |
| 52-Week Low | 6.47 |
| Moving Average 50 Days | 8.73 |
| Moving Average 200 Days | 8.49 |
| Average Volume | 12,196 |
| Shares Outstanding | 6.58M |
| % Held by Institutions | 14.21 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:14 |
| Last Split Date | March 16, 2026 |